Pompeo praises India for lifting export restrictions on critical medical supplies

WASHINGTON: On Wednesday, US Secretary of State Mike Pompeo praised India for lifting export bans on critical medical supplies, including pharmaceuticals used to treat patients with COVID-19, and said it was an example to work together with partner countries to face the challenges posed by the coronavirus pandemic. .
"We are working with our friends in Australia, India and Japan, New Zealand, the Republic of Korea and Vietnam to share information and best practices as we begin to boost the world economy," Pompeo told reporters at a press conference. here.
"Our conversation certainly involved global supply chains, keeping them running smoothly, bringing our economies back to full strength and thinking about how we restructure supply chain changes to prevent something like this from happening again," he said. .
The coronavirus has infected more than three million people and has claimed more than 211,000 lives worldwide.
"An example of our joint work is with India. Export bans on critical medical supplies, including pharmaceuticals used to treat some patients with COVID-19, were lifted," Pompeo said.
In the past few weeks, he has spoken by phone, at least four times, with Foreign Minister S Jaishankar. Reading the calls indicated that securing the global supply chain figured prominently in their conversations.
Pompeo said that the US government. USA It has provided more than $ 32 million in funds to support the COVID-19 response in the Pacific Island countries.
"We are working with the Burmese government, the United Nations, NGOs and others to prevent the spread of COVID-19 in Burma, even among vulnerable populations," he said.
Referring to a recent report, Pompeo said Americans have dedicated nearly $ 6.5 billion in government and non-government contributions to help countries fight COVID-19.
"This is by far the largest total country in the world and more than 12 times that of China's combined contributions," he said.

.

Leave a Comment

Your email address will not be published. Required fields are marked *

Scroll to Top